At a glance
ClinicalIndex Comparison RecordN/ACompleted· 111 enrolled
Drug / intervention
Stannous fluoride toothpaste +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An 8-Week, Randomized, Controlled, Examiner-Blind, Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentin Hypersensitivity in a Population of Dentin Hypersensitivity Sufferers
In Brief
A clinical study evaluating Stannous fluoride toothpaste and Crest cavity protection toothpaste for Dentin Sensitivity. Completed, enrolled 111 participants across 1 site.
Detailed Summary
The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartMar 2024
First PostedApr 2024
Primary CompletionJun 2024
TodayJul 2026
First PostedApr 11, 2024
Enrollment StartMar 25, 2024
Primary CompletionJun 20, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.2 years ago
Interventions
Stannous fluoride toothpastedrug
Toothpaste containing 0.454 % weight/weight (w/w) SnF2
Crest cavity protection toothpastedrug
Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.